Portopulmonary hypertension and the liver transplant candidate

Paul C. Kuo, Jeffrey S. Plotkin, Sean Gaine, Rebecca A. Schroeder, Vinod K. Rustgi, Lewis J. Rubin, Lynt B. Johnson

Research output: Contribution to journalArticle

117 Scopus citations

Abstract

The management of the liver transplant (OLT) candidate with portopulmonary hypertension (PPHTN) has dramatically changed in the past 3 years. Careful preoperative evaluation with functional characterization of right ventricular function plays a critical role. The pulmonary vascular response to epoprostenol infusion serves as a deciding factor for OLT candidacy. Careful perioperative attention to avoid right ventricular failure from acutely elevated pulmonary artery pressures or sudden increases in right ventricular preload is a key physiologic tenet of management. With increased surgical expertise, anesthetic sophistication, and availability of epoprostenol, PPHTN is no longer considered an absolute contraindication for OLT.

Original languageEnglish (US)
Pages (from-to)1087-1093
Number of pages7
JournalTransplantation
Volume67
Issue number8
DOIs
StatePublished - Apr 27 1999
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Transplantation

Fingerprint Dive into the research topics of 'Portopulmonary hypertension and the liver transplant candidate'. Together they form a unique fingerprint.

  • Cite this

    Kuo, P. C., Plotkin, J. S., Gaine, S., Schroeder, R. A., Rustgi, V. K., Rubin, L. J., & Johnson, L. B. (1999). Portopulmonary hypertension and the liver transplant candidate. Transplantation, 67(8), 1087-1093. https://doi.org/10.1097/00007890-199904270-00001